Article Type

436 - 450 of 1364 Results       Clear All

New Clues to Delta Variant’s Spread in Studies of Virus-Like Particles

Gladstone in the News November 18, 2021

New Clues to Delta Variant’s Spread in Studies of Virus-Like Particles

NIH Director’s Blog—The Delta variant of SARS-CoV-2 is driving the latest surge of COVID-19 cases in the United States. New research from Senior Investigators Jennifer Doudna and Melanie Ott explains how mutations in this variant increase transmissibility.

Gladstone Experts COVID-19 Infectious Disease Doudna Lab Ott Lab

Unique Repurposing Approach Identifies Potential Alzheimer’s Disease Drug

Gladstone in the News November 16, 2021

Unique Repurposing Approach Identifies Potential Alzheimer’s Disease Drug

BioIT World—Despite decades of research, medical therapies for Alzheimer’s disease have so far proven elusive. Senior Investigator Yadong Huang describes how his innovative approach to drug repurposing has identified a promising candidate drug that is now moving toward clinical trials.

Gladstone Experts Alzheimer’s Disease Neurological Disease Huang Lab

SF Researchers Find Possible Breakthrough in Treating Traumatic Brain Injuries

Gladstone in the News November 9, 2021

SF Researchers Find Possible Breakthrough in Treating Traumatic Brain Injuries

ABC News—Traumatic brain injuries can result in sleep disruptions and seizures. Gladstone Associate Investigator Jeanne Paz describes her team’s recent identification of an immune molecule that may be key to these symptoms, and the potential to treat brain injury survivors with new therapies.

Gladstone Experts Traumatic Brain Injury Neurological Disease Paz Lab

COVID’s Cardiac Connection

Gladstone in the News November 3, 2021

COVID’s Cardiac Connection

Scientific American—There is increasing evidence that some people who recover from COVID-19 suffer from lingering heart problems, a phenomenon known as post-COVID-19 cardiac syndrome. Senior Investigator Bruce Conklin explains that it’s important to investigate the long-term consequences of infection, and describes his team’s work showing that infecting heart cells with SARS-CoV-2 can result in dramatic structural damage.

Gladstone Experts COVID-19 Cardiovascular Disease Conklin Lab

How the Next Generation of COVID-19 Vaccines Could Lead To “Sterilizing Immunity”

Gladstone in the News November 3, 2021

How the Next Generation of COVID-19 Vaccines Could Lead To “Sterilizing Immunity”

San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on a potentially new type of COVID-19 vaccine that would fight the virus at its points of entry—the nose, throat, or lungs—and may provide even better protection than current shots in the arm.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Definition of ‟Fully Vaccinated” Could Change, CDC Chief Says. Here’s What That Means

Gladstone in the News October 28, 2021

Definition of ‟Fully Vaccinated” Could Change, CDC Chief Says. Here’s What That Means

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, puts the CDC's definition of "fully vaccinated" in the context of our constantly evolving understanding of the COVID-19 pandemic.

Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab

‟Hybrid Immunity”: Why COVID Vaccination May Give Extra-Strong Protection after Infection

Gladstone in the News October 21, 2021

‟Hybrid Immunity”: Why COVID Vaccination May Give Extra-Strong Protection after Infection

San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, explains that people who receive COVID-19 vaccination after having had the disease harbor special immune cells that may provide stronger and more durable protection against future infections.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media